Introduction
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Diabetes mellitus includes type-1 diabetes mellitus and type-2 diabetes mellitus (T2DM), and the incidence of diabetes mellitus has increased dramatically over the last several decades. 4 Diabetic nephropathy (DN), a serious complication of diabetes mellitus, includes type-1 diabetic nephropathy (T1DN) due to type-1 diabetes mellitus and T2DN due to T2DM. 4, 5 Some 30-40% of diabetic patients develop DN, associated with a poor life expectancy and end-stage renal disease, causing serious socioeconomic problems. 6 The present epidemiologic study aims to evaluate the association of the ACE I/D gene polymorphism in the etiology of T2DN and the risk of patients with T2DM developing T2DN. However, the available evidence reported to date is weak, due to sparseness of data or disagreements among studies. There is little meta-analysis exploring the association of ACE I/D gene polymorphism with T2DN susceptibility and the risk of patients with T2DM developing T2DN in Caucasian populations. We performed this meta-analysis from all reports published in English to investigate the relationship between ACE I/D gene polymorphism and T2DN susceptibility and the risk of patients with T2DM developing T2DN in Caucasian populations, with the intention to provide a much more reliable finding on the significance of the association.
Materials and methods

Search strategy
Relevant studies were identified from the PubMed and Cochrane Library electronic databases on 1 March 2014. The term "(diabetic nephropathy) AND (angiotensinconverting enzyme) AND (polymorphism OR variant)" was entered into PubMed and the Cochrane Library. The search in PubMed was limited to humans and English language. We also extended the search spectrum to the "related articles" and the bibliographies of all recruited studies. If multiple publications from the same study group occurred, we only used the most complete paper for our analysis.
Inclusion and exclusion criteria
Inclusion criteria were: (1) a case-control study; (2) the outcome had to be T2DN; (3) there had to be at least two comparison groups (T2DN group vs. control group); and (4) the study should be conducted in a Caucasian population.
Exclusion criteria were: (1) review articles, editorials and case reports; (2) articles that did not provide detailed genotype data; (3) articles investigating the association of other genes with T2DN; (4) articles investigating the role of ACE in diseases; and (5) multiple publications of the same data from the same study group.
Data extraction and synthesis
The following information was extracted from each study independently by two investigators: first author's surname, year of publication, ethnicity of study population, and the number of cases and controls for ACE I/D genotype. Frequencies of the D allele were calculated for case group and control group, from the corresponding genotype distribution. The results were compared and disagreements were resolved by discussion.
Statistical analysis
Available data were entered into Cochrane Review Manager (RevMan, version 5, Oxford, UK) and analyzed. The pooled statistic was counted using the fixed-effects model, but a random-effects model was conducted when the p-value of heterogeneity test was less than 0.1. Results were expressed with odds ratios (OR) for dichotomous data, and 95% confidence intervals (CI) were also calculated. A value of p < 0.05 was required for the overall OR to be deemed statistically significant. I 2 was used to test the heterogeneity between the included studies. Sensitivity analysis was performed according to sample size of case (<100 vs. ≥100). The Begg adjusted rank correlation test 18 and the Egger regression asymmetry test 19 were used for exploring publication bias (p < 0.1 was considered significant) when the sample number was more than 10.
Results
Study characteristics
The search yielded 261 references, 260 from PubMed and one from Cochrane Library. According to the inclusion and exclusion criteria, 16 articles 7-22 were identified for the analysis of ACE I/D gene polymorphism and T2DN susceptibility and the risk of T2DM developing into T2DN in Caucasian populations in our review. Five studies [7] [8] [9] [10] [11] were conducted on the relationship between ACE I/D gene polymorphism and T2DN susceptibility (Table 1) , and 15 rep orts 7-10,12-22 were conducted on the relationship between ACE I/D gene polymorphism and the susceptibility of T2DM developing into T2DN ( Table 2 ).
Association of the ACE I/D gene polymorphisms with T2DN risk
In this meta-analysis, ACE I/D gene polymorphisms was not associated with T2DN risk in Caucasian populations (D allele: OR = 1.10, 95% CI: 0.95-1.28, p = 0.19; DD genotype: OR = 1.11, 95% CI: 0.84-1.47, p = 0.46; II genotype: OR = 0.97, 95% CI: 0.69-1.37, p = 0.87; Figure  1 and Table 3 ).
Sensitivity analysis for the relationship between ACE I/D gene polymorphism and T2DN risk in Caucasian populations was also performed according to sample size of case (<100 vs. ≥100). We found that the results were similar to the non-sensitivity analysis. ACE I/D gene polymorphisms were not associated with T2DN risk in Caucasian populations ( Table 3 ).
Association of ACE I/D gene polymorphisms with the risk of T2DM patients developing into T2DN
In this meta-analysis, ACE I/D gene polymorphisms were also not associated with the risk of patients with T2DM developing T2DN in Caucasian populations (D allele: OR = 1.10, 95% CI: 0.97-1.26, p = 0.15; DD genotype: OR = 1.08, 95% CI: 0.97-1.20, p = 0.16; II genotype: OR = 0.92, 95% CI: 0.81-1.04, p = 0.16; Figure 2 for D allele, Figure 3 for DD genotype and Figure 4 for II genotype; Table 3 ).
Sensitivity analysis for the relationship between ACE I/D gene polymorphism and the risk of T2DM developing into T2DN in Caucasian populations was also performed according to sample size of case (<100 vs. ≥100). We found that the results were similar to the non-sensitivity analysis. ACE I/D gene polymorphisms were not associated with the risk of patients with T2DM developing T2DN in Caucasian populations ( Table 3 ).
Evaluation of publication bias
No significant publication bias was found in the comparison of T2DN vs. T2DM (Begg p = 1.000, Egger p = 0.895; Figure 5 for Begg test).
discussion
The dysfunction of ACE generation brought about by gene polymorphism is considered the major deterioration factor to associated with T2DN susceptibility and the risk of patients with T2DM developing T2DN in Caucasian populations. There are few data about genetic molecular markers 29  48  22  30  7  59  74  118  Araz, 2001  34  64  18  116  132  232  43  57  23 123  143  246  Fradin, 2002  38  61  18  117  137  234  44  54  20 118  142  236  Hadjadj, 2003  1119 1468 552 3139 3706  6278  208 282 115 605  698  1210  Arzu Ergen, 2004  9  11  5  25  29  50  24  21  5  50  69  100  Canani, 2005  126  181  66  373  433  746  181 308 120 609  670  1218  Eroglu 2008  16  17  13  46  49  92  19  24  13  56  62  112  Palomo-Piñón, 2009  43  105  87  235  191  470  24  91  85 200  139  400 to predict the onset of T2DN and the risk of patients with T2DM developing into T2DN in Caucasian populations. This meta-analysis was performed to explore whether the ACE I/D gene polymorphism could predict the susceptibility of T2DN susceptibility and the risk of patients with T2DM developing into T2DN in Caucasian populations. Al-Rubeaan et al. 23 conducted a meta-analysis to explore the relationship between ACE I/D gene polymorphism and the risk of T2DM, and reported that the ACE I/D polymorphism was found to be significantly associated with T2DM risk among the Arab population, whereas among Caucasians, this association was not found. However, was there an association between ACE I/D gene polymorphism and T2DN susceptibility or the risk of patients with T2DM developing into T2DN in Caucasian population? The metaanalysis was performed to assess this relationship.
In our meta-analysis, the relationship between ACE I/D gene polymorphism and the susceptibility of T2DN in Caucasian populations was assessed. We found that ACE I/D gene polymorphism was not associated with T2DN susceptibility in Caucasian populations. Furthermore, the results from the sensitivity analysis were similar to those from the non-sensitivity analysis. However, the number of included studies was small (only five studies included for meta-analysis), and the evidence was less robust. More studies should be performed in the future.
In this meta-analysis, the relationship between ACE I/D gene polymorphism and the risk of patients with T2DM developing T2DN in Caucasian populations was also assessed. We found that ACE I/D gene polymorphism was not associated with T2DN susceptibility. Furthermore, the results from the sensitivity analysis were similar to those from the non-sensitivity analysis, and there was no significant publication bias. The number of included studies was large, and the evidence may be robust to some extent.
In our investigation, we found that ACE I/D gene polymorphism was not associated with T2DN susceptibility and the risk of patients with T2DM developing T2DN. However, these findings should be regarded with caution because many other factors, such as heterogeneity of enrolled cases, limited statistical power, variable study designs and different interventions, could affect the results. Undoubtedly, the limitations mentioned above might affect our final conclusions.
In conclusion, the results in our study support that ACE I/D gene polymorphism was not associated with T2DN susceptibility and the risk of patients with T2DM developing T2DN in Caucasian populations. However, more association investigations on larger, stratified populations are required to further clarify the role of ACE I/D gene polymorphism in T2DN susceptibility and the risk of patients with T2DM developing T2DN in Caucasian populations. 
